In contrast, in a recently conducted IHC-based study16, high CYP27A1 protein expression was conversely associated with a higher incidence of disease recurrence among patients younger than 55 years with ER+ tumors, raising questions about the true significance of CYP27A1 in premenopausal BC. This evidence concerns the gene CYP27A1 and breast cancer.